Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Contribution of sphingosine kinase (SPK)-catalyzed production of sphingosine-1-phosphate (SPP), in comparison to
phospholipase C
(
PLC
), to Ca(2+) signalling by epidermal growth factor (EGF) was studied in two HEK-293 cell clones (HEK2 and
HEK3
), expressing functional EGF receptors and exhibiting release of stored Ca(2+) by intracellular SPP. In
HEK3
cells, EGF increased [Ca(2+)](i) and stimulated both, SPK and
PLC
. [Ca(2+)](i) increase, but not
PLC
stimulation, was strongly reduced by SPK inhibition. In HEK2 cells, EGF similarly stimulated
PLC
, but did not increase [Ca(2+)](i) or stimulate SPK, suggesting that intracellular SPP production plays a major role for Ca(2+) signalling by EGF in HEK-293 cells.
...
PMID:Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor. 1056